EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Daphnetin Alleviates Bleomycin-Induced Pulmonary Fibrosis through Inhibition of Epithelial-to-Mesenchymal Transition and IL-17A

Soo-Jin Park iD, Hyung Won Ryu iD, Ji-Hyeong Kim iD, Hwa-Jeong Hahn, Hyun-Jae Jang iD, Sung-Kyun Ko iD, Sei-Ryang Oh iD, Hyun-Jun Lee iD

Cells · 08.12.2023 · 12 (24) · 2795

DOI: 10.3390/cells12242795 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 08.12.2023. Verfasst von Soo-Jin Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Natural Product Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju-si 28116, Republic of Korea. Hauptthemen laut MEDLINE: Bleomycin, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Research Institute of Bioscience and Biotechnology, National Research Foundation of Korea, KRIBB Research Initiative Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic and refractory interstitial lung disease. Although there is no cure for IPF, the development of drugs with improved efficacy in the treatment of IPF is required. Daphnetin, a natural coumarin derivative, has immunosuppressive, anti-inflammatory, and antioxidant activities. However, its antifibrotic effects have not yet been elucidated. In this study, we investigated the antifibrotic effects of daphnetin on pulmonary fibrosis and the associated molecular mechanism. We examined the effects of daphnetin on splenocytes cultured in Th17 conditions, lung epithelial cells, and a mouse model of bleomycin (BLM)-induced pulmonary fibrosis. We identified that daphnetin inhibited IL-17A production in developing Th17 cells. We also found that daphnetin suppressed epithelial-to-mesenchymal transition (EMT) in TGF-β-treated BEAS2B cells through the regulation of AKT phosphorylation. In BLM-treated mice, the oral administration of daphnetin attenuated lung histopathology and improved lung mechanical functions. Our findings clearly demonstrated that daphnetin inhibited IL-17A and EMT both in vitro and in vivo, thereby protecting against BLM-induced pulmonary fibrosis. Taken together, these results suggest that daphnetin has potent therapeutic effects on lung fibrosis by modulating both Th17 differentiation and the TGF-β signaling pathway, and we thus expect daphnetin to be a drug candidate for the treatment of IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BleomycinIdiopathic Pulmonary FibrosisMiceAnimalsInterleukin-17Transforming Growth Factor betaUmbelliferones

Stichwörter der Autor:innen

IL-17ATGF-βTh17daphnetinidiopathic pulmonary fibrosis

Substanzen

BleomycinInterleukin-17Transforming Growth Factor betadaphnetinUmbelliferones

Autor:innen und Institutionen

  • Natural Product Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju-si 28116, Republic of Korea.
  • Department of Biomolecular Science, University of Science & Technology (UST), Daejeon 34113, Republic of Korea.
  • Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju-si 28116, Republic of Korea.

ORCID-Profile: Soo-Jin Park, Hyung Won Ryu, Ji-Hyeong Kim, Hyun-Jae Jang, Sung-Kyun Ko, Sei-Ryang Oh, Hyun-Jun Lee

Förderung

  • Korea Research Institute of Bioscience and Biotechnology
  • National Research Foundation of Korea
  • KRIBB Research Initiative Program

Zitieren

APA

Park, S. J., Ryu, H. W., Kim, J. H., Hahn, H. J., Jang, H. J., Ko, S. K., Oh, S. R., & Lee, H. J. (2023). Daphnetin Alleviates Bleomycin-Induced Pulmonary Fibrosis through Inhibition of Epithelial-to-Mesenchymal Transition and IL-17A. Cells, 12(24), 2795. https://doi.org/10.3390/cells12242795

Vancouver

Park SJ, Ryu HW, Kim JH, Hahn HJ, Jang HJ, Ko SK, et al. Daphnetin Alleviates Bleomycin-Induced Pulmonary Fibrosis through Inhibition of Epithelial-to-Mesenchymal Transition and IL-17A. Cells. 2023;12(24):2795. doi:10.3390/cells12242795

BibTeX
@article{Park2023,
  author = {Park, Soo-Jin and Ryu, Hyung Won and Kim, Ji-Hyeong and Hahn, Hwa-Jeong and Jang, Hyun-Jae and Ko, Sung-Kyun and Oh, Sei-Ryang and Lee, Hyun-Jun},
  title = {Daphnetin Alleviates Bleomycin-Induced Pulmonary Fibrosis through Inhibition of Epithelial-to-Mesenchymal Transition and IL-17A},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {24},
  pages = {2795},
  doi = {10.3390/cells12242795}
}
Kostenlos starten →